Neuronal ceroid lipofuscinosis

Acronym

Definition

NCL

Norwegian Cruise Line

NCL

New Caledonia (ISO Country code)

NCL

National Consumers League (Washington, DC)

NCL

National Charity League

NCL

Neuronal Ceroid Lipofuscinosis (adult type)

NCL

National Civic League

NCL

Nanotechnology Characterization Laboratory

NCL

Nintendo Co. Ltd.

NCL

NCAR Command Language

NCL

National Cricket League (UK)

NCL

National Chemical Laboratory, India (Pune, India)

NCL

National Commission on Libraries

NCL

No Climb (established)

NCL

Net Credit Loss

NCL

Newcastle, England, United Kingdom - International (Airport Code)

NCL

National Chess League (1976-1983?)

NCL

National Core Library (South Africa)

NCL

National Curriculum Level (UK education)

NCL

Network Centric Logistics

NCL

Night Carrier Landing

NCL

New Church Leadership

NCL

National Centre for Languages (aka CILT; UK)

NCL

New Company Law

NCL

Null Convention Logic (digital circuit design)

NCL

New Canadian Library (McClelland)

NCL

Neighbor Cell List (telecommunications)

NCL

National Centre for Labour (India)

NCL

National Coalfields Ltd (India)

NCL

Non-Vomputing module Load

References in periodicals archive	?		Acronyms browser	?		Full browser	?
Palo Alto, CA, announced it has received approval from the Institutional Review Board (IRB) of the Oregon Health & Science University (OHSU), Portland, OR, to initiate a Phase I clinical trial of the company's proprietary human neural stem cell product - HuCNS-SC - to treat infantile and late-infantile neuronal ceroid lipofuscinosis (NCL), two forms of a group of disorders often referred to as Batten disease. StemCells receives IRB approval from OHSU to begin Phase I clinical ... by Transplant News StemCells has completed a Phase I clinical trial of its HuCNS-SC cells for the treatment of a Neuronal Ceroid Lipofuscinosis (NCL), a fatal brain disorder in children. StemCells, Inc. CEO Martin McGlynn Featured On BioBusiness.TV's "Stem ... by Business Wire The proposed Phase 1 trial is designed to evaluate the safety and preliminary efficacy of HuCNS-SC for the treatment of infantile and late-infantile neuronal ceroid lipofuscinosis (NCL), the most severe forms of a group of disorders commonly referred to as Batten disease. StemCells gets FDA ok to begin phase I clinical trial to transplant ... by Transplant News	NETWIB NETWORK NetWoRM NETZINE NEU NEUA NEUC NEUD NEUDC NEUF NEUFIE NEUFODI NEUI NEUL NEUM NEUPG NEUQ NEUR neurelitism NEURO- NEUROBOT NEUROCOLT NEUROD NEUROD1 NEURON Neuronal ceroid lipofuscinosis NEURONET NEUROQUACS NEURS NEUS NEUST NEUT NEUTRA NEUTRABAS NEUYM NEV NEVA NEVAC NEVACC NEVADA NEVB NEVBA NEVC NEVCA NEVCC NEVCO NEVD NEVDGP NEVDIS NEVE NEVES	Neuron Interactive Virtual Reality Neuron Interactive Virtual Reality Neuron Interactive Virtual Reality Neuron Interactive Virtual Reality Neuron Number Control 1 Neuron Restrictive Silencer Element Neuron Restrictive Silencer Factor Neuron theory neuron transmission neuron transmission neuron transmission Neuron-glia Cell Adhesion Molecule Neuron-specific enolase Neuron-specific enolase Neuron-specific enolase Neuron-specific enolase neuronal neuronal neuronal neuronal abiotrophy neuronal abiotrophy neuronal antibody Neuronal Apoptosis Inhibitory Protein Neuronal Apoptosis Inhibitory Protein 1 Neuronal cell adhesion molecule Neuronal cell adhesion molecule Neuronal Cell Nuclear Factor Neuronal Ceroid Lipofuscinoses Neuronal Ceroid Lipofuscinoses Research Neuronal Ceroid Lipofuscinoses Research Alliance Neuronal ceroid lipofuscinosis Neuronal Ceroid-Lipofuscinosis Neuronal Ceroid-Lipofuscinosis Neuronal Conditioned Medium neuronal gap junctions neuronal glycoproteinosis neuronal glycoproteinosis Neuronal Group Selection Theory neuronal heterotopia neuronal heterotopia neuronal inclusion-body disease neuronal inclusion-body disease neuronal interface Neuronal Intermediate Filament Inclusion Disease Neuronal intestinal dysplasia Neuronal Intestinal Dysplasia Type B Neuronal Intranuclear Inclusion Disease Neuronal KappaB-Binding Factor Neuronal Kinesin Heavy Chain Neuronal Leucine-Rich Repeat neuronal lipodystrophy neuronal lipodystrophy Neuronal loss Neuronal loss Neuronal loss Neuronal Network Model Neuronal Nicotinic Acetylcholine Receptor Neuronal Nicotinic Acetylcholine Receptor Alpha 4 Subunit Neuronal Nicotinic Receptor Neuronal Nitric Oxide Synthase Neuronal Nitric Oxide Synthase

References in periodicals archive

Acronyms browser

Full browser

Palo Alto, CA, announced it has received approval from the Institutional Review Board (IRB) of the Oregon Health & Science University (OHSU), Portland, OR, to initiate a Phase I clinical trial of the company's proprietary human neural stem cell product - HuCNS-SC - to treat infantile and late-infantile neuronal ceroid lipofuscinosis (NCL), two forms of a group of disorders often referred to as Batten disease.

StemCells receives IRB approval from OHSU to begin Phase I clinical ... by Transplant News

StemCells has completed a Phase I clinical trial of its HuCNS-SC cells for the treatment of a Neuronal Ceroid Lipofuscinosis (NCL), a fatal brain disorder in children.

StemCells, Inc. CEO Martin McGlynn Featured On BioBusiness.TV's "Stem ... by Business Wire

The proposed Phase 1 trial is designed to evaluate the safety and preliminary efficacy of HuCNS-SC for the treatment of infantile and late-infantile neuronal ceroid lipofuscinosis (NCL), the most severe forms of a group of disorders commonly referred to as Batten disease.

StemCells gets FDA ok to begin phase I clinical trial to transplant ... by Transplant News